These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas. Levin VA, Yung WK, Bruner J, Kyritsis A, Leeds N, Gleason MJ, Hess KR, Meyers CA, Ictech SA, Chang E, Maor MH. Int J Radiat Oncol Biol Phys; 2002 May 01; 53(1):58-66. PubMed ID: 12007942 [Abstract] [Full Text] [Related]
3. Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children. Levin VA, Lamborn K, Wara W, Davis R, Edwards M, Rabbitt J, Malec M, Prados MD. Neuro Oncol; 2000 Jan 01; 2(1):22-8. PubMed ID: 11302250 [Abstract] [Full Text] [Related]
4. Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma. Buckner JC, Shaw EG, Pugh SL, Chakravarti A, Gilbert MR, Barger GR, Coons S, Ricci P, Bullard D, Brown PD, Stelzer K, Brachman D, Suh JH, Schultz CJ, Bahary JP, Fisher BJ, Kim H, Murtha AD, Bell EH, Won M, Mehta MP, Curran WJ. N Engl J Med; 2016 Apr 07; 374(14):1344-55. PubMed ID: 27050206 [Abstract] [Full Text] [Related]
6. PC or PCV, That Is the Question: Primary Anaplastic Oligodendroglial Tumors Treated with Procarbazine and CCNU With and Without Vincristine. Webre C, Shonka N, Smith L, Liu D, De Groot J. Anticancer Res; 2015 Oct 07; 35(10):5467-72. PubMed ID: 26408710 [Abstract] [Full Text] [Related]
8. Combined treatment modality for anaplastic oligodendroglioma: a phase II study. Jeremic B, Shibamoto Y, Gruijicic D, Milicic B, Stojanovic M, Nikolic N, Dagovic A, Aleksandrovic J. J Neurooncol; 1999 Jun 07; 43(2):179-85. PubMed ID: 10533731 [Abstract] [Full Text] [Related]
9. High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma. Abrey LE, Childs BH, Paleologos N, Kaminer L, Rosenfeld S, Salzman D, Finlay JL, Gardner S, Peterson K, Hu W, Swinnen L, Bayer R, Forsyth P, Stewart D, Smith AM, Macdonald DR, Weaver S, Ramsey DA, Nimer SD, DeAngelis LM, Cairncross JG. J Neurooncol; 2003 Nov 07; 65(2):127-34. PubMed ID: 14686732 [Abstract] [Full Text] [Related]
11. Conformal irradiation for pure and mixed oligodendroglioma: the experience of Centre Leon Berard Lyon. Sunyach MP, Pommier P, Martel Lafay I, Guyotat J, Ginestet G, Jouanneau E, Jouvet A, Sindou M, Bret P, Carrie C, Frappaz D. Int J Radiat Oncol Biol Phys; 2003 May 01; 56(1):296-303. PubMed ID: 12694851 [Abstract] [Full Text] [Related]
16. Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402. Wang M, Cairncross G, Shaw E, Jenkins R, Scheithauer B, Brachman D, Buckner J, Fink K, Souhami L, Laperriere N, Mehta M, Curran W, Radiation Therapy Oncology Group (RTOG), North Central Cancer Treatment Group (NCCTG), Southwest Oncology Group (SWOG), National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), Eastern Cooperative Oncology Group (ECOG). Int J Radiat Oncol Biol Phys; 2010 Jul 01; 77(3):662-9. PubMed ID: 19783377 [Abstract] [Full Text] [Related]
18. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy. Glass J, Hochberg FH, Gruber ML, Louis DN, Smith D, Rattner B. J Neurosurg; 1992 May 22; 76(5):741-5. PubMed ID: 1564535 [Abstract] [Full Text] [Related]
19. Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold C. J Clin Oncol; 1994 Oct 22; 12(10):2013-21. PubMed ID: 7931469 [Abstract] [Full Text] [Related]
20. Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study. Jeremic B, Grujicic D, Antunovic V, Djuric L, Stojanovic M, Shibamoto Y. Int J Radiat Oncol Biol Phys; 1994 Dec 01; 30(5):1179-85. PubMed ID: 7961028 [Abstract] [Full Text] [Related] Page: [Next] [New Search]